These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21388432)

  • 1. Advances in membranous nephropathy: success stories of a long journey.
    Ronco P; Debiec H
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):460-6. PubMed ID: 21388432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2010 Apr; 21(4):564-9. PubMed ID: 20185638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2005 May; 16(5):1205-13. PubMed ID: 15800120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.
    Ronco P; Debiec H
    Pflugers Arch; 2017 Aug; 469(7-8):997-1005. PubMed ID: 28597189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte antigens and glomerular disease.
    Ronco P; Debiec H
    Nephron Exp Nephrol; 2007; 107(2):e41-6. PubMed ID: 17726340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.
    Ronco P; Debiec H
    Semin Immunopathol; 2007 Nov; 29(4):445-58. PubMed ID: 17899086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranous glomerulopathy: the evolving story.
    Ronco P; Debiec H
    Curr Opin Nephrol Hypertens; 2010 May; 19(3):254-9. PubMed ID: 20110811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-childhood membranous nephropathy due to cationic bovine serum albumin.
    Debiec H; Lefeu F; Kemper MJ; Niaudet P; Deschênes G; Remuzzi G; Ulinski T; Ronco P
    N Engl J Med; 2011 Jun; 364(22):2101-10. PubMed ID: 21631322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient].
    Ronco P; Debiec H
    Biol Aujourdhui; 2013; 207(4):249-59. PubMed ID: 24594573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular biology of membranous nephropathy.
    Couser WG; Nangaku M
    J Nephrol; 2006; 19(6):699-705. PubMed ID: 17173240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of immune complexes in membranous nephropathy.
    Xu J; Hu H; Sun Y; Zhao Z; Zhang D; Yang L; Lu Q
    Front Immunol; 2024; 15():1441017. PubMed ID: 39185424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extra-membranous glomerulonephritis: from the experimental model to the human pathology of new-born and adult].
    Ronco P
    Bull Mem Acad R Med Belg; 2008; 163(3-4):179-86; discussion 186-8. PubMed ID: 19025206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy.
    Hu P; Xuan Q; Hu B; Lu L; Qin YH
    Mol Biol Rep; 2013 Apr; 40(4):2963-7. PubMed ID: 23271116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis.
    Meyer-Schwesinger C; Dehde S; Klug P; Becker JU; Mathey S; Arefi K; Balabanov S; Venz S; Endlich KH; Pekna M; Gessner JE; Thaiss F; Meyer TN
    J Immunol; 2011 Sep; 187(6):3218-29. PubMed ID: 21844386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
    Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
    Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the pathogenesis of membranous glomerulonephritis.
    Ronco P; Debiec H
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):258-63. PubMed ID: 16609292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
    Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranous nephropathy and malignancy.
    Beck LH
    Semin Nephrol; 2010 Nov; 30(6):635-44. PubMed ID: 21146128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey.
    Glassock RJ
    Am J Kidney Dis; 2010 Jul; 56(1):157-67. PubMed ID: 20378220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.